(18.97.14.87)
[ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2019, Volume : 12, Issue : 8
First page : ( 3581) Last page : ( 3588)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2019.00611.5

Synthesis, Identification, Theoretical Study and effect of 1,3,4-Oxadiazole Compounds Substituted on Creatinine ring on the activity of some Transfers Enzymes

Khudhair Zahraa T.*, Al-Tamimi Entesar O.

Department of Chemistry, College of Science, University of Baghdad, Jadiriya, Baghdad, Iraq

*Corresponding Author E-mail: zzo64052@gmail.com

Online published on 24 December, 2019.

Abstract

The present report describes the synthesis of 1,3,4-oxadiazole compounds on shiff base substituted on creatinine ring, the Synthetic route started from reaction shiff base derivatives with α-chloroethylacetate to give compounds(1e-2e). Hydrazide derivatives were synthesized by the reaction compounds (1e-2e) with hydrazine hydrate to give compounds (3e-4e). The compounds (3e-4e) reacts with phenylisothiocyanate to give compounds (5e-6e). The synthesized compounds characterized by FT-IR and 1HNMR spectroscopy. Beside the experimental work, we worked theoretical study involving calculated the spectra, total energy, dipole moment etc. Also this study was designed to show the effects of creatinine derivatives on the activities of some transferase enzymes such as: GOT, and GPT enzymes in sera. This compounds demonstrated activation effects on GOT and GPT activities. These effects increased with increasing the concentration of the compounds. The causes of the increases in the enzymes activities are discussed.

Top

Keywords

Oxadiazole, GOT, GPT, Shiff base, Sera, Spectra.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
850,833,720 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.